Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT)
2025-524939-39-02Phase 2Authorised
- Sponsor
- Slagelse Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of PEX010 in anorexia nervosa (AN) and atypical anorexia nervosa (AAN) (2 arms), sponsored by Slagelse Hospital. Planned start Aug 2026; status: authorised.
02
Drugs
PEX010
03
Conditions
anorexia nervosa (AN)atypical anorexia nervosa (AAN)
Beyond the preview
Go deeper on 2025-524939-39-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524939-39-02.